ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Oramed Pharmaceuticals (ORMP) Technical (Analysis) Reports Oramed Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Oramed Pharmaceuticals (ORMP)

Technical Analysis Report for NASDAQ stock ORMP Oramed Pharmaceuticals. Dated: 31 Mar 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock ORMP Oramed Pharmaceuticals then click here. or read Experts views on Oramed Pharmaceuticals or Forecast & share price targets of Oramed Pharmaceuticals

Oramed Pharmaceuticals Opened at 3.33 and Closed at: 3.40, which is 3.24% of previous session's close. It moved within a range of 3.28 and 3.44
The session was a Bullish session with an average volume of 64200, which is -8.6% of previous session's volumes.

    A Golden cross was found 7 days back on short term averages

    Support for tomorrow is 3.34 and resistance for tomorrow is 3.5
    These support and resistance points are valid for the first 5-15 minutes charts

    Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

    Support for tomorrow's hourly charts is 3.31, 3.21 resistance for tomorrow's hourly charts is 3.47, 3.53

    10 Day SMA for Oramed Pharmaceuticals (ORMP) is 3.45 and stock is trading below these levels. This is not a good sign for its short term trend

    20 Day SMA for Oramed Pharmaceuticals (ORMP) is 3.42 and the stock is trading below these levels. This is not a good sign for its mid term trend

    50 Day SMA for Oramed Pharmaceuticals (ORMP) is 3.39 and the stock is trading above these levels. This is a good sign for its mid to long term trend

    100 Day SMA is 3.12 and the stock is trading above these levels. This is a good sign for its long term trend

    200 Day SMA Oramed Pharmaceuticals is 2.69 and stock is trading above these levels. This is a good sign for its long term trend

    20 DMA of Oramed Pharmaceuticals is at 3.42 and 200 DMA is at 2.69, while 50 DMA and 100 DMA are at 3.39 and 3.12 respectively

    Oramed Pharmaceuticals (ORMP) moving average of 20 SMA is at 3.42 and 20 EMA is at 3.42

    Oramed Pharmaceuticals (ORMP) moving average of 50 SMA is at 3.39 and 50 EMA is at 3.34

    Oramed Pharmaceuticals (ORMP) moving average of 100 SMA is at 3.12 and 100 EMA is at 3.17

    Oramed Pharmaceuticals (ORMP) moving average of 200 SMA is at 2.69 and 200 EMA is at 2.94

    Luminex Corporation has performed better than Oramed Pharmaceuticals in short term. You could have earned much better returns by investing in Luminex Corporation, about 36.97% more returns!

    Exelixis Inc has performed better than Oramed Pharmaceuticals in short term. You could have earned much better returns by investing in Exelixis Inc, about 4.69% more returns!

    Oramed Pharmaceuticals Technical analysis of indicators

    Price action analysis of Oramed Pharmaceuticals (ORMP) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small

    ADX buy sell signal for Oramed Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.

    MACD generated a SELL signal for Oramed Pharmaceuticals in short term but the sell signal is initial and weak.

    Oramed Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!

    Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up

    CCI has generated a buy signal for Oramed Pharmaceuticals in short term but BUY signal is weak.

    RSI is generating a SELL signal in short term but selling is losing momentum.

    MRSI is in positive zone. This is a BUY zone

    Although the stock is in the BUY zone, but buying might be slowing down

    Stock of Oramed Pharmaceuticals is picking up selling momentum according to indicator.

    Volume based indicators are showing selling momentum.

    Volume Weighted Averaged Price (VWAP) for short term is 3.45 and Oramed Pharmaceuticals ORMP stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

    People seem to be coming out and selling the Oramed Pharmaceuticals ORMP stock. Volume based technical analysis of Oramed Pharmaceuticals ORMP stock is negative.

    Oramed Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive

    Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

    Tomorrow's Predictions

    You should also read Tomorrow's Movement Predictions for NASDAQ stock ORMP Oramed Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!

    And ORMP Experts View which covers a lot of information including buying and selling signals

    ORMP future forecast & share price targets

    You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Oramed Pharmaceuticals or View Candle Stick Charts here

    Chart Oramed Pharmaceuticals (ORMP)  Technical (Analysis) Reports Oramed Pharmaceuticals [

    Videos related to: Oramed Pharmaceuticals (ORMP) Technical (Analysis) Reports Oramed Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

    Hindi Basics How To Trade In FnO Futures Options Stock Market

    Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You

    Oramed Pharmaceuticals (ORMP)  Technical (Analysis) Reports Oramed Pharmaceuticals [

     

    Back to top